Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.38
0.032.22%
Last update: Dec 15, 9:23 AM
Comments
Loading...
Coherus Oncology (CHRS) Stock Price, Quote, News & History
CHRSNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Coherus Oncology (CHRS) stock?
You can purchase shares of Coherus Oncology (NASDAQ:CHRS) through any online brokerage.
Who are Coherus Oncology (CHRS) competitors?
Other companies in Coherus Oncology’s space includes: Molecular Partners AG (NASDAQ:MOLN), Kalaris Therapeutics Inc (NASDAQ:KLRS), Innate Pharma SA (NASDAQ:IPHA), Gain Therapeutics Inc (NASDAQ:GANX) and Burning Rock Biotech Ltd (NASDAQ:BNR).
What is the forecast, or price target, for Coherus Oncology (CHRS) stock?
Coherus Oncology has a consensus price target of $6.29.
What is the current price for Coherus Oncology (CHRS)?
The stock price for Coherus Oncology (NASDAQ: CHRS) is $1.38 last updated December 15, 2025 at 9:23 AM EST.
Does Coherus Oncology (CHRS) pay a dividend?
There are no upcoming dividends for Coherus Oncology.
When is Coherus Oncology (NASDAQ:CHRS) reporting earnings?
Coherus Oncology does not have any upcoming earnings scheduled.
Is Coherus Oncology (CHRS) going to split?
There is no upcoming split for Coherus Oncology.
What sector and industry does Coherus Oncology (CHRS) operate in?
Coherus Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
